Literature DB >> 19725100

Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms.

Mohammad Sawal1, Marta Cohen, Jose E Irazuzta, Ramani Kumar, Christine Kirton, Marie-Anne Brundler, Clair Anne Evans, John Andrew Wilson, Parakkal Raffeeq, Amer Azaz, Alexandre T Rotta, Ajay Vora, Amit Vohra, Patricia Abboud, L David Mirkin, Mehrengise Cooper, Megan K Dishop, Jeanine M Graf, Andy Petros, Hilary Klonin.   

Abstract

Pertussis carries a high risk of mortality in very young infants. The mechanism of refractory cardio-respiratory failure is complex and not clearly delineated. We aimed to examine the clinico-pathological features and suggest how they may be related to outcome, by multi-center review of clinical records and post-mortem findings of 10 patients with fulminant pertussis (FP). All cases were less than 8 weeks of age, and required ventilation for worsening respiratory symptoms and inotropic support for severe hemodynamic compromise. All died or underwent extra corporeal membrane oxygenation (ECMO) within 1 week. All had increased leukocyte counts (from 54 to 132 x 10(9)/L) with prominent neutrophilia in 9/10. The post-mortem demonstrated necrotizing bronchitis and bronchiolitis with extensive areas of necrosis of the alveolar epithelium. Hyaline membranes were present in those cases with viral co-infection. Pulmonary blood vessels were filled with leukocytes without well-organized thrombi. Immunodepletion of the thymus, spleen, and lymph nodes was a common feature. Other organisms were isolated as follows; 2/10 cases Para influenza type 3, 2/10 Moraxella catarrhalis, 1/10 each with respiratory syncytial virus (RSV), a coliform organism, methicillin-resistant Staphylococcus aureus (MRSA), Haemophilus influenzae, Stenotrophomonas maltophilia, methicillin-sensitive Staphylococcus aureus (MSSA), and candida tropicalis. We postulate that severe hypoxemia and intractable cardiac failure may be due to the effects of pertussis toxin, necrotizing bronchiolitis, extensive damage to the alveolar epithelium, tenacious airway secretions, and possibly leukostasis with activation of the immunological cascade, all contributing to increased pulmonary vascular resistance. Cellular apoptosis appeared to underlay much of these changes. The secondary immuno-compromise may facilitate co-infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725100     DOI: 10.1002/ppul.21082

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  29 in total

1.  Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Authors:  Karen M Scanlon; Yael Gau; Jingsong Zhu; Ciaran Skerry; Susan M Wall; Manoocher Soleimani; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

2.  Severe Pertussis Pneumonia managed with Exchange Transfusion.

Authors:  Said Al Hanshi; Mohammed Al Ghafri; Suad Al Ismaili
Journal:  Oman Med J       Date:  2014-05

Review 3.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

Review 4.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

Review 5.  Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.

Authors:  Bradley S Podd; Dennis W Simon; Santiago Lopez; Andrew Nowalk; Rajesh Aneja; Joseph A Carcillo
Journal:  Pediatr Clin North Am       Date:  2017-08-18       Impact factor: 3.278

Review 6.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

7.  Fatal Pertussis in the Neonatal Mouse Model Is Associated with Pertussis Toxin-Mediated Pathology beyond the Airways.

Authors:  Karen M Scanlon; Yael G Snyder; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

8.  Dual infection with Bordetella pertussis and Mycoplasma pneumoniae in three infants: case reports.

Authors:  A Zouari; A Touati; H Smaoui; D Brun; K Kasdaghli; K Menif; N Ben Jaballah; E Ben Hassen; N Guiso; A Kechrid
Journal:  Infection       Date:  2011-08-23       Impact factor: 3.553

9.  Histopathology of Bordetella pertussis in the Baboon Model.

Authors:  Lindsey I Zimmerman; James F Papin; Jason Warfel; Roman F Wolf; Stanley D Kosanke; Tod J Merkel
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

10.  Sphingosine-1-phosphate Receptor Agonism Reduces Bordetella pertussis-mediated Lung Pathology.

Authors:  Ciaran Skerry; Karen Scanlon; Hugh Rosen; Nicholas H Carbonetti
Journal:  J Infect Dis       Date:  2014-12-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.